Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

148.09
+2.061.41%
Post-market: 148.090.00000.00%19:33 EDT
Volume:1.65M
Turnover:243.90M
Market Cap:282.56B
PE:20.71
High:148.95
Open:147.21
Low:146.90
Close:146.03
52wk High:170.46
52wk Low:97.72
Shares:1.91B
Float Shares:1.82B
Volume Ratio:0.77
T/O Rate:0.09%
Dividend:4.67
Dividend Rate:3.15%
EPS(TTM):7.15
EPS(LYR):7.15
ROE:30.81%
ROA:11.14%
PB:6.13
PE(LYR):20.71

Loading ...

Novartis shareholders approve all resolutions proposed by Board of Directors

TIPRANKS
·
Mar 06

Berenberg Raises Price Target on Novartis to $141 From $116, Keeps Hold Rating

MT Newswires Live
·
Mar 06

Second HeLa Lawsuit Resolved As Novartis Reaches Confidential Settlement

Benzinga_recent_news
·
Mar 01

Tariffs Influenced Novartis to Build Over 7 Plants in US, Trump Says

MT Newswires Live
·
Feb 28

Trump says ‘tariffs have influenced’ Novartis to build 7+ facilities

TIPRANKS
·
Feb 28

Atrium Therapeutics Begins Operations With 2 Precision Cardiology Candidates

MT Newswires Live
·
Feb 27

Novartis completes acquisition of Avidity Biosciences

TIPRANKS
·
Feb 27

Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy

GlobeNewswire
·
Feb 27

Novartis Says EMA Panel Recommends Remibrutinib for Chronic Spontaneous Urticaria

MT Newswires Live
·
Feb 27

Novartis receives positive CHMP opinion for remibrutinib in CSU

TIPRANKS
·
Feb 27

Novartis to build radioligand therapy site in Denton, Texas

TIPRANKS
·
Feb 25

COLUMN-Novartis quietly settles Henrietta Lacks suit as family’s legal push gains steam

Reuters
·
Feb 24

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Feb 24

Novartis to Divest Majority Stake in Indian Subsidiary for $159 Million

Deep News
·
Feb 20

Trump Asserts Novartis Establishing Eleven Manufacturing Plants in the United States

Deep News
·
Feb 20

Unnatural Products in Pact With Novartis to Develop Macrocyclic Peptide Therapeutics

Dow Jones
·
Feb 18

U.S. RESEARCH ROUNDUP-Brixmor Property, Mohawk Industries, UDR

Reuters
·
Feb 17

Novartis on Track for Record High Closing -- Data Talk

Dow Jones
·
Feb 14

Novartis Says Vanrafia Late-Stage Data Support Slowing of Kidney Function Decline in IgA Nephropathy Patients

MT Newswires Live
·
Feb 13

Novartis price target raised to CHF 135 from CHF 125 at JPMorgan

TIPRANKS
·
Feb 13